Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Physiol Pharmacol ; 1986 Oct-Dec; 30(4): 307-12
Article Dans Anglais | IMSEAR | ID: sea-108020

Résumé

Tranylcypromine (TCP) pretreatment was found to accelerate the tremorogenic activity of tremorine in rats. Conversely, reserpinization delayed the onset of induction of tremors, and a significant diminution in their intensity was observed in these rats. A comparative study of the antitremor activity of beta-adrenoceptor antagonists against this tremor-model showed that butoxamine (beta 2-antagonist) and propranolol (nonselective antagonist) were able to afford a rapid and powerful protection, whereas a weaker and delayed effect was observed in rats treated with the beta 1-antagonist, acebutolol. Furthermore, the antitremor activity of butoxamine and propranolol but not that of acebutolol was found to be potentiated and diminished in rats pretreated with reserpine and TCP, respectively. It was inferred that beta 2-receptor modulated the tremorogenic activity of tremorine, and that inhibition by propranolol or butoxamine of this subtype beta-adrenoceptor resulted in rapid and powerful suppression of tremors, and that the antiadrenergic activity of acebutolol was unlikely to have a role in its antitremor effect.


Sujets)
Antagonistes bêta-adrénergiques/pharmacologie , Animaux , Relation dose-effet des médicaments , Femelle , Mâle , Rats , Récepteur muscarinique/effets des médicaments et des substances chimiques , Réserpine/pharmacologie , Système nerveux sympathique/physiologie , Tranylcypromine/pharmacologie , Tremblement/induit chimiquement , Trémorine/antagonistes et inhibiteurs
SÉLECTION CITATIONS
Détails de la recherche